Intervertebral disc degeneration is rescued by TGFβ/BMP signaling modulation in an ex vivo filamin B mouse model
Open Access
- 26 April 2022
- journal article
- research article
- Published by Springer Nature in Bone Research
- Vol. 10 (1) , 1-12
Abstract
Spondylocarpotarsal syndrome (SCT) is a rare musculoskeletal disorder characterized by short stature and vertebral, carpal, and tarsal fusions resulting from biallelic nonsense mutations in the gene encoding filamin B (FLNB). Utilizing a FLNB knockout mouse, we showed that the vertebral fusions in SCT evolved from intervertebral disc (IVD) degeneration and ossification of the annulus fibrosus (AF), eventually leading to full trabecular bone formation. This resulted from alterations in the TGFβ/BMP signaling pathway that included increased canonical TGFβ and noncanonical BMP signaling. In this study, the role of FLNB in the TGFβ/BMP pathway was elucidated using in vitro, in vivo, and ex vivo treatment methodologies. The data demonstrated that FLNB interacts with inhibitory Smads 6 and 7 (i-Smads) to regulate TGFβ/BMP signaling and that loss of FLNB produces increased TGFβ receptor activity and decreased Smad 1 ubiquitination. Through the use of small molecule inhibitors in an ex vivo spine model, TGFβ/BMP signaling was modulated to design a targeted treatment for SCT and disc degeneration. Inhibition of canonical and noncanonical TGFβ/BMP pathway activity restored Flnb−/− IVD morphology. These most effective improvements resulted from specific inhibition of TGFβ and p38 signaling activation. FLNB acts as a bridge for TGFβ/BMP signaling crosstalk through i-Smads and is key for the critical balance in TGFβ/BMP signaling that maintains the IVD. These findings further our understanding of IVD biology and reveal new molecular targets for disc degeneration as well as congenital vertebral fusion disorders.Keywords
Funding Information
- March of Dimes Foundation
- Joseph Drown Foundation
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (F31 AR066487)
- Ministerstvo Školství, Mládeže a Tělovýchovy (LTAUSA19030)
- Agency for Healthcare Research of the Czech Republic
This publication has 85 references indexed in Scilit:
- A Restricted Spectrum of Mutations in the SMAD4 Tumor-Suppressor Gene Underlies Myhre SyndromeThe American Journal of Human Genetics, 2012
- Smad6 is essential to limit BMP signaling during cartilage developmentJournal of Bone and Mineral Research, 2011
- TGF-β signaling plays an essential role in the growth and maintenance of intervertebral disc tissueFEBS Letters, 2011
- Ubiquitin Ligase Nedd4L Targets Activated Smad2/3 to Limit TGF-β SignalingMolecular Cell, 2009
- Bone morphogenetic protein receptors and signal transductionThe Journal of Biochemistry, 2009
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- Signaling cross-talk between TGF-β/BMP and other pathwaysCell Research, 2008
- TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcAThe EMBO Journal, 2007
- Disruption of the Flnb gene in mice phenocopies the human disease spondylocarpotarsal synostosis syndromeHuman Molecular Genetics, 2007
- Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent mannerJournal of Cell Biology, 2007